Literature DB >> 16125466

T cell subset and cytokine profiles in human visceral leishmaniasis during active and asymptomatic or sub-clinical infection with Leishmania donovani.

Asrat Hailu1, Debbie van Baarle, Gerlinde J Knol, Nega Berhe, Frank Miedema, Piet A Kager.   

Abstract

During an epidemiological study of visceral leishmaniasis (VL) in south-west Ethiopia, 33 VL patients, 9 treated VL patients, 14 individuals with sub-clinical infection, 34 individuals with asymptomatic infection, and 19 healthy controls were studied for T cell subsets and cytokine profiles. Negative leishmanin skin test, CD3 and CD4 lymphocytopenia, and significantly reduced numbers of memory CD4+ T cells were found in VL patients compared to treated VL patients or persons with self-limiting asymptomatic infection. The proportion of CD4+ and CD8+ T cells that produced IFN-gamma and IL-4 after stimulation with PMA (Phorbol 12-myristate 13-acetate) and ionomycin was significantly reduced in VL patients compared to sub-clinical and asymptomatic infections or healthy controls. Plasma concentrations of IFN-gamma and IL-10 were elevated in VL.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16125466     DOI: 10.1016/j.clim.2005.06.015

Source DB:  PubMed          Journal:  Clin Immunol        ISSN: 1521-6616            Impact factor:   3.969


  35 in total

Review 1.  Systematic review of biomarkers to monitor therapeutic response in leishmaniasis.

Authors:  Anke E Kip; Manica Balasegaram; Jos H Beijnen; Jan H M Schellens; Peter J de Vries; Thomas P C Dorlo
Journal:  Antimicrob Agents Chemother       Date:  2014-11-03       Impact factor: 5.191

2.  Interleukin-27 (IL-27) Mediates Susceptibility to Visceral Leishmaniasis by Suppressing the IL-17-Neutrophil Response.

Authors:  Gustavo F S Quirino; Manuela S L Nascimento; Marcela Davoli-Ferreira; Lais A Sacramento; Mikhael H F Lima; Roque P Almeida; Vanessa Carregaro; João Santana Silva
Journal:  Infect Immun       Date:  2016-07-21       Impact factor: 3.441

Review 3.  Immunopathogenesis of non-healing American cutaneous leishmaniasis and progressive visceral leishmaniasis.

Authors:  Lynn Soong; Calvin A Henard; Peter C Melby
Journal:  Semin Immunopathol       Date:  2012-10-11       Impact factor: 9.623

4.  CD45RO+ T Cells and T Cell Activation in the Long-Lasting Immunity after Leishmania infantum Infection.

Authors:  João F Rodrigues-Neto; Gloria R Monteiro; Tatjana S L Keesen; Henio G Lacerda; Edgar M Carvalho; Selma M B Jeronimo
Journal:  Am J Trop Med Hyg       Date:  2017-12-21       Impact factor: 2.345

5.  CCR7+ central and CCR7- effector memory CD4+ T cells in human cutaneous leishmaniasis.

Authors:  Hossein Keshavarz Valian; Mahmoud Nateghi Rostami; Minoo Tasbihi; Akram Miramin Mohammadi; Seyed Ebrahim Eskandari; Abdolfattah Sarrafnejad; Ali Khamesipour
Journal:  J Clin Immunol       Date:  2012-09-19       Impact factor: 8.317

6.  Asymptomatic Leishmania infection: a new challenge for Leishmania control.

Authors:  Om Prakash Singh; Epco Hasker; David Sacks; Marleen Boelaert; Shyam Sundar
Journal:  Clin Infect Dis       Date:  2014-02-27       Impact factor: 9.079

7.  Human Interleukin-32γ Plays a Protective Role in an Experimental Model of Visceral Leishmaniasis in Mice.

Authors:  Leo A B Joosten; Fátima Ribeiro-Dias; Rodrigo Saar Gomes; Muriel Vilela Teodoro Silva; Jéssica Cristina Dos Santos; Christine van Linge; Juliana Machado Reis; Mauro Martins Teixeira; Sebastião Alves Pinto; Miriam Leandro Dorta; Xiyuan Bai; Edward D Chan; Charles A Dinarello; Milton Adriano Pelli Oliveira
Journal:  Infect Immun       Date:  2018-04-23       Impact factor: 3.441

8.  Hybrid cell vaccination resolves Leishmania donovani infection by eliciting a strong CD8+ cytotoxic T-lymphocyte response with concomitant suppression of interleukin-10 (IL-10) but not IL-4 or IL-13.

Authors:  Rajatava Basu; Suniti Bhaumik; Arun Kumar Haldar; Kshudiram Naskar; Tripti De; Syamal Kumar Dana; Peter Walden; Syamal Roy
Journal:  Infect Immun       Date:  2007-10-01       Impact factor: 3.441

Review 9.  Immunoregulation in human American leishmaniasis: balancing pathology and protection.

Authors:  K J Gollob; A G Viana; W O Dutra
Journal:  Parasite Immunol       Date:  2014-08       Impact factor: 2.280

10.  American tegumentary leishmaniasis: T-cell differentiation profile of cutaneous and mucosal forms-co-infection with Trypanosoma cruzi.

Authors:  Cecilia Parodi; María F García Bustos; Alejandra Barrio; Federico Ramos; Ana G González Prieto; María C Mora; Patricia Baré; Miguel A Basombrío; María M de Elizalde de Bracco
Journal:  Med Microbiol Immunol       Date:  2016-04-04       Impact factor: 3.402

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.